Smith & Wesson Brands, Inc. (NASDAQ:SWBI) Q3 2026 Earnings Call Transcript March 5, 2026 Smith & Wesson Brands, Inc. misses on earnings expectations. Reported EPS is $0.08 EPS, expectations were $0.23 ...

Apple's budget-focused MacBook Neo borrows the A18 Pro chip from an iPhone 16 Pro. Here's how the chip compares against other Apple Silicon Macs, and why it's actually a pretty smart thing for Apple ...

Global automotive steering wheel switch market is valued at approximately USD 1.84 billion in 2023 and is projected to grow with a robust CAGR of around 2.3% over the forecast period 2024-2032. Read ...

Agora, Inc. (NASDAQ: API) (the “Company”), a pioneer and leader in conversational AI and real-time engagement technology, today announced its unaudited financial results for the fourth quarter and ...

Zhao, J. and Xu, J. (2026) The Impact of Moral Distress on Nurses Work Alienation in Third Grade Class-A Hospital in Wuhan. Yangtze Medicine, 10, 1-9. doi: 10.4236/ym.2026.101001 .

| DelveInsight The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based ...

Q4 2025 Earnings Call March 3, 2026 10:00 AM ESTCompany ParticipantsAndy Wedderburn-MaxwellKenneth Leonard - Co-CEO ...

Q3 2026 Earnings Call March 5, 2026 5:00 PM ESTCompany ParticipantsKevin Maxwell - Senior VP, General Counsel, ...

DelveInsight forecasts a rise in the drug-resistant epilepsy market from 2025 to 2034, driven by higher prevalence, improved diagnosis, treatment advances, aging demographics, increased awareness, and ...

This paper examines whether Chinese development finance is associated with faster progress toward Millennium Development Goal style targets in low- and middle-income countries. We combine AidData’s ...

LandBridge Company LLC (NYSE: LB) (the "Company," or "LandBridge") today announced its financial and operating results for the fourth quarter and fiscal year ended December 31, 2025.

Objective Geriatric patients often face issues related to polypharmacy and adverse drug events. Re-evaluating prescribed medications and considering deprescribing is critical. Medication discrepancies ...